Glioblastoma-EV-delivered miR-30b-3p has been shown both in vitro and in vivo to decrease apoptosis and increase proliferation by directly targeting RHOB, offering a potential treatment strategy for glioblastoma [51]. This evidence concerns the gene RHOB and glioblastoma.